Keywords: valeant, begins, enrollment, ph, iib, taribavirin, trial

Valeant begins enrollment in Ph IIb taribavirin trial

Article | 26 March 2007

California, USA-based drugmaker Valeant Pharmaceuticals says it has begun enrolling patients in a Phase IIb trial of its developmental antiviral ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Valeant Pharmaceuticals

Go to company listing